The development of an automated in situ assay for the detection of human cytomegalovirus in peripheral blood leukocytes.
Human cytomegalovirus (HCMV) infections are common in immunosuppressed patients, especially transplant recipients and patients with AIDS. The utility of an automated in situ hybridization (ISH) assay for the rapid detection of HCMV immediate early mRNA was evaluated using cytospin (Shandon Lipshaw, Inc., Pittsburgh, PA) prepared leukocytes from peripheral blood samples. In this study, the detection of HCMV immediate early protein by immunofluorescent antibody staining of the standard shell vial assay was compared to the detection of HCMV immediate early mRNA in peripheral blood leukocytes using the automated ISH system. Of 135 specimens tested, eight specimens were positive using HCMV ISH compared to seven positive specimens using shell vial assay. Overall, HCMV ISH demonstrated 100% sensitivity and 99% specificity. Since the HCMV ISH assay requires minimal labor, and can be completed in less than 5 h, this method should be evaluated as a potential replacement for shell vial assay for the diagnosis of HCMV infection.
Baunoch
D A
DA
Department of Pathology, The University of Chicago, IL, USA.
Lobell
A
A
Kane
D
D
Fredericks
J
J
Thompson
K D
KD
D003587:Cytomegalovirus / Q000235:genetics / Q000302:isolation & purification*; D005347:Fibroblasts / Q000737:chemistry / Q000821:virology; D006801:Humans; D017874:Immediate-Early Proteins / Q000235:genetics; D017403:In Situ Hybridization / Q000295:instrumentation / Q000379:methods; D007962:Leukocytes / Q000737:chemistry / Q000821:virology*; D012333:RNA, Messenger / Q000235:genetics; D012367:RNA, Viral / Q000235:genetics
D017874:Immediate-Early Proteins; D012333:RNA, Messenger; D012367:RNA, Viral; C052612:cytomegalovirus immediate early phosphoprotein pp89